ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
Sandy's Scandals Column
Past and current Scandals
- columns by Sandy Gottstein (aka Mintz)*
* March 16, 2010 - Sebelius
Asks Media to Censor Autism Debate By Katie Wright - Age of Autism
- "I am taking Ms. Sebelius at her word. Ms. Sebelius has unilaterally
said that she knows that every single American parent who saw their
child regress post vaccination or experience a severe adverse reaction
is wrong and she knows better. Ms. Sebelius has ordered, suggested,
beseeched, implored (?) American journalists NOT to 'give these people
(anyone concerned with vaccine safety) equal weight in their reporting'
because she has decided by informal governmental decree that the debate
is closed?"
* March 16, 2010
- FDA
pandemic guidance is “unnecessarily burdensome” - GSK, Genentech,
BIO and PDA have stated that it is “unnecessarily burdensome” for
pandemic production plans to conform to parts of 21 CFR and requested
that the FDA revises its draft guidance. - Outsourcing-Pharma.com - "In
its response the Biotechnology Industry Organization (BIO) stated that
requiring the high absenteeism production plans to conform to specific
parts of 21 CFR “is unnecessarily burdensome and provides no value to
ensuring protection of the public health”. BIO recommends that plans
are designed to support conformance to good manufacturing practices but
are maintained in business documents, not the change control system.
GlaxoSmithKline (GSK), Genentech and Parenteral Drug Association (PDA)
have similar views."